Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Allergan plc buy melinda

Start price
€213.82
21.03.17
Target price
€248.05
Performance (%)
3.130%
End price
€216.67
06.12.18

According to melinda what are the pros and cons of Allergan plc for the foreseeable future?

Comments by melinda for this prediction

In the thread Allergan plc diskutieren

Published 21.03.17
Prediction Buy
Perf. (%) 3.130%
Target price 248.050
Change

Allergan FDA



Allergan erhielt die Genehmigung von der US Food and Drug Administration (FDA) Juvederm XC VOLLURETM, zur Korrektur von mittelschweren bis schweren Gesichtsfalten und Falten, wie Nasolabialfalten, bei älteren Erwachsenen über 21 auf den Markt.


Published 06.12.18
Prediction Buy
Perf. (%) 3.130%
Target price 248.050
Change

(Laufzeit überschritten)

Stopped prediction by melinda for Allergan plc

Allergan plc

Start price
Target price
Perf. (%)
€147.75
€180.40
21.636%

Allergan plc

Start price
Target price
Perf. (%)
€123.52
€130.79
21.900%

Allergan plc

Start price
Target price
Perf. (%)
€213.78
€202.95
3.814%